Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Molecular Cancer Research : MCR|July 19, 2014
Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADDAnuja Chattopadhyay, Brian L Hood, Thomas P Conrads, et al.Leukemia Research|November 5, 2013
Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockadeElizabeth A Rush, Sheri L Pollock, Irina Abecassis, et al.Leukemia Research|March 1, 2006
The NPM-RAR fusion protein associated with the t(5;17) variant of APL does not interact with PMLElizabeth A Rush, Kimberly W Schlesinger, Simon C Watkins, et al.Leukemia & Lymphoma|January 13, 2016
The leukemic oncoprotein NPM1-RARA inhibits TP53 activityErin M Swaney, Anuja Chattopadhyay, Irina Abecassis, et al.Expert Review of Hematology|September 21, 2012
A clinical algorithm predicts hematological complications in Shwachman-Diamond syndrome?Johnson M LiuCancer Chemotherapy and Pharmacology|May 27, 2008
Effect of antacid on imatinib absorptionBrian A Sparano, Merrill J Egorin, Robert A Parise, et al.Experimental Biology and Medicine (Maywood, N.J.)|January 24, 2022
Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?Johnson M Liu, Jeffrey ChiLeukemia & Lymphoma|October 29, 2009
Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicinWassim McHayleh, Rajesh Sehgal, Robert L Redner, et al.Blood|March 2, 2006
Ribosomes and marrow failure: coincidental association or molecular paradigm?Johnson M Liu, Steven R EllisBritish Journal of Haematology|November 20, 2008
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trialsJames N George, Susan D Mathias, Ronald S Go, et al.Pageof 7